Jiangyi Yu

1.2k total citations
49 papers, 623 citations indexed

About

Jiangyi Yu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Jiangyi Yu has authored 49 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Nephrology. Recurrent topics in Jiangyi Yu's work include Chronic Kidney Disease and Diabetes (7 papers), Advanced Glycation End Products research (7 papers) and Cancer-related molecular mechanisms research (5 papers). Jiangyi Yu is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Advanced Glycation End Products research (7 papers) and Cancer-related molecular mechanisms research (5 papers). Jiangyi Yu collaborates with scholars based in China, Macao and Australia. Jiangyi Yu's co-authors include Xinyi Sun, Xiaofei An, Juan Chen, Zilin Sun, Xiaohang Wang, Chunhua Wu, Yue Zhao, Xin Wang, Nan Li and Lifang Ye and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and Medicine.

In The Last Decade

Jiangyi Yu

44 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangyi Yu China 13 199 135 97 82 79 49 623
Xuemei Wang China 18 237 1.2× 82 0.6× 112 1.2× 80 1.0× 59 0.7× 37 731
Nur Samsu Indonesia 6 210 1.1× 141 1.0× 195 2.0× 78 1.0× 36 0.5× 26 689
De Jin China 15 347 1.7× 113 0.8× 100 1.0× 63 0.8× 198 2.5× 52 835
Fen Yuan China 12 243 1.2× 94 0.7× 87 0.9× 92 1.1× 28 0.4× 20 670
Haitao Shen China 17 306 1.5× 112 0.8× 54 0.6× 76 0.9× 43 0.5× 32 773
Bin Gao China 17 194 1.0× 186 1.4× 82 0.8× 148 1.8× 44 0.6× 46 728
Motoaki Komatsu Japan 11 236 1.2× 102 0.8× 155 1.6× 164 2.0× 31 0.4× 28 734
Dafa Ding China 15 497 2.5× 79 0.6× 89 0.9× 181 2.2× 30 0.4× 22 823
Hengjiang Guo China 13 247 1.2× 56 0.4× 196 2.0× 135 1.6× 52 0.7× 14 647
Yongli Zhan China 13 185 0.9× 85 0.6× 203 2.1× 97 1.2× 49 0.6× 33 636

Countries citing papers authored by Jiangyi Yu

Since Specialization
Citations

This map shows the geographic impact of Jiangyi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangyi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangyi Yu more than expected).

Fields of papers citing papers by Jiangyi Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangyi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangyi Yu. The network helps show where Jiangyi Yu may publish in the future.

Co-authorship network of co-authors of Jiangyi Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangyi Yu. A scholar is included among the top collaborators of Jiangyi Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangyi Yu. Jiangyi Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Yong, Wei-Long Xu, Beverly E. Sha, et al.. (2025). Quercetin ameliorates renal injury by promoting UCP1-mediated alleviation of lipid accumulation in diabetic kidney disease. Phytomedicine. 147. 157213–157213.
2.
3.
Zhou, Peipei, et al.. (2024). Association between gut microbiota and diabetic microvascular complications: a two-sample Mendelian randomization study. Frontiers in Endocrinology. 15. 1364280–1364280. 7 indexed citations
4.
Xu, Yu, et al.. (2024). Myricetin induces M2 macrophage polarization to alleviate renal tubulointerstitial fibrosis in diabetic nephropathy via PI3K/Akt pathway. World Journal of Diabetes. 15(1). 105–125. 9 indexed citations
5.
Song, Siyuan, Qiling Zhang, Li Zhang, Xiqiao Zhou, & Jiangyi Yu. (2024). A two-sample bidirectional Mendelian randomization analysis investigates associations between gut microbiota and type 2 diabetes mellitus. Frontiers in Endocrinology. 15. 1313651–1313651. 7 indexed citations
6.
Wang, Xuening, et al.. (2023). Hyperuricemia Predicts the Progression of Type 2 Diabetic Kidney Disease in Chinese Patients. Diabetes Therapy. 14(3). 581–591. 7 indexed citations
7.
Zhou, Peipei, et al.. (2023). Effects of Niaoduqing granules on inflammatory response of diabetic kidney disease: A meta‑analysis. Experimental and Therapeutic Medicine. 26(4). 494–494.
8.
Sun, Jing, et al.. (2022). Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis. Frontiers in Immunology. 13. 1089469–1089469. 9 indexed citations
9.
Chen, Juan, Hong Sun, Shanhu Qiu, et al.. (2021). Lipid Accumulation Product Combined With Urine Glucose Excretion Improves the Efficiency of Diabetes Screening in Chinese Adults. Frontiers in Endocrinology. 12. 691849–691849. 10 indexed citations
10.
Li, Nan, Lifang Ye, Changyin Li, et al.. (2021). Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway. Frontiers in Medicine. 8. 656086–656086. 21 indexed citations
11.
Zhang, Shu, et al.. (2021). Hyperoside Protects HK-2 Cells Against High Glucose-Induced Apoptosis and Inflammation via the miR-499a-5p/NRIP1 Pathway. Pathology & Oncology Research. 27. 629829–629829. 24 indexed citations
12.
Chen, Juan, Chunhua Wu, Xiaohang Wang, Jiangyi Yu, & Zilin Sun. (2020). The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 11. 574541–574541. 80 indexed citations
13.
14.
Yu, Jiangyi. (2010). Evaluation of Clinical Therapeutic Effect of the Method for Nourishing Yin and Activating Blood Circulation on Diabetic Peripheral Neuropathy. Zhonghua zhongyiyao xuekan. 2 indexed citations
15.
Wang, Lijuan, Jiangyi Yu, & Mei Luo. (2009). Clinical research of early stage of diabetic feet with TCM internal and external.. Zhonghua zhongyiyao zazhi. 24(8). 1004–1006. 1 indexed citations
16.
Yan, Ming, et al.. (2009). Central administration of kisspeptin-10 inhibits natriuresis and diuresis induced by blood volume expansion in anesthetized male rats. Acta Pharmacologica Sinica. 31(2). 145–149. 15 indexed citations
17.
18.
Yu, Jiangyi, Xiaofei An, Xin Wang, et al.. (2009). Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage. Diabetes Research and Clinical Practice. 87(2). 157–160. 11 indexed citations
19.
Yu, Jiangyi. (2007). Influence study of traditional Chinese medicine on inflammatory factor of type 2 diabetes in earlier period. 1 indexed citations
20.
Guo, Daqing & Jiangyi Yu. (1997). Clinical study on effect of TCM treatment in decreasing frequency of peritoneal dialysis. Chinese Journal of Integrated Traditional and Western Medicine. 3(1). 6–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuemei Wang Breakdown of academic impact, for papers by Nur Samsu Breakdown of academic impact, for papers by De Jin Breakdown of academic impact, for papers by Fen Yuan Breakdown of academic impact, for papers by Haitao Shen Breakdown of academic impact, for papers by Bin Gao Breakdown of academic impact, for papers by Motoaki Komatsu Breakdown of academic impact, for papers by Dafa Ding Breakdown of academic impact, for papers by Hengjiang Guo Breakdown of academic impact, for papers by Yongli Zhan
Rankless by CCL
2026